Elliott J Mufson Selected Research

complement C3a receptor

10/2022

Complement C3a Receptor (C3aR) Mediates Vascular Dysfunction, Hippocampal Pathology, and Cognitive Impairment in a Mouse Model of VCID.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elliott J Mufson Research Topics

Disease

93	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 02/2002
60	Cognitive Dysfunction 10/2022 - 02/2002
15	Down Syndrome (Down's Syndrome) 01/2021 - 11/2002
12	Dementia (Dementias) 01/2021 - 02/2002
8	Disease Progression 02/2020 - 07/2006
8	Amyloid Plaque 12/2019 - 09/2005
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 05/2009
4	Parkinson Disease (Parkinson's Disease) 10/2013 - 01/2006
3	Atrophy 10/2022 - 01/2017
3	Prodromal Symptoms 01/2021 - 04/2005
2	Hypertrophy 01/2019 - 01/2006
2	Intellectual Disability (Idiocy) 05/2017 - 01/2016
1	Brain Ischemia (Cerebral Ischemia) 10/2022
1	Amyloid angiopathy 11/2021
1	Neuroinflammatory Diseases 11/2020
1	Necrosis 01/2020
1	AIDS-Related Complex (ARC) 01/2019
1	Gliosis 01/2019
1	Experimental Arthritis 10/2018
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2018
1	Classical Lissencephalies and Subcortical Band Heterotopias 01/2018
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2017
1	Brain Diseases (Brain Disorder) 11/2017
1	Neurobehavioral Manifestations 01/2017
1	Brain Concussion (Cerebral Concussion) 01/2016
1	Trisomy (Trisomies) 01/2016
1	Chronic Traumatic Encephalopathy 01/2016
1	Inflammation (Inflammations) 01/2015
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 10/2013

Drug/Important Bio-Agent (IBA)

35	Cholinergic Agents (Cholinergics)IBA 01/2019 - 02/2002
29	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2003
23	Amyloid (Amyloid Fibrils)IBA 11/2021 - 09/2005
17	Nerve Growth Factor (NGF)IBA 01/2021 - 08/2003
13	Amyloid beta-PeptidesIBA 01/2022 - 02/2005
11	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2005
8	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 04/2015 - 02/2002
8	GalaninIBA 01/2011 - 04/2002
7	Choline (Choline Chloride)IBA 01/2021 - 10/2013
7	Peptides (Polypeptides)IBA 01/2019 - 11/2007
6	Nerve Growth Factors (Neurotrophins)IBA 01/2019 - 10/2003
6	EnzymesIBA 01/2018 - 02/2003
4	Messenger RNA (mRNA)IBA 01/2021 - 01/2008
4	AntibodiesIBA 01/2021 - 01/2010
4	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 01/2021 - 04/2005
3	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2006
3	tau Proteins (tau Protein)IBA 11/2020 - 01/2016
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2019 - 06/2005
3	Apolipoproteins E (ApoE)IBA 01/2016 - 01/2016
3	SynaptophysinIBA 01/2012 - 06/2006
2	Glial Fibrillary Acidic ProteinIBA 02/2020 - 01/2019
2	Sirtuin 1IBA 01/2018 - 01/2015
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018 - 06/2005
2	Intravenous Immunoglobulins (IVIG)FDA Link 07/2014 - 01/2014
2	U1 Small Nuclear RibonucleoproteinIBA 04/2014 - 10/2013
2	Dichlororibofuranosylbenzimidazole (DRB)IBA 01/2012 - 06/2006
2	Estrogens (Estrogen)FDA Link 01/2012 - 11/2002
2	Synaptotagmins (Synaptotagmin)IBA 01/2012 - 06/2006
2	rab GTP-Binding ProteinsIBA 10/2011 - 01/2010
2	ImmunosorbentsIBA 05/2009 - 08/2003
2	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 04/2005 - 02/2002
1	complement C3a receptorIBA 10/2022
1	CalbindinsIBA 01/2021
1	Calcium-Binding ProteinsIBA 01/2021
1	ParvalbuminsIBA 01/2021
1	Calbindin 2IBA 01/2021
1	Cathepsin DIBA 11/2020
1	neuronal pentraxinIBA 02/2020
1	ChitinasesIBA 02/2020
1	Complement C1q (C1q Complement)IBA 02/2020
1	CalciumIBA 02/2020
1	Myristoylated Alanine-Rich C Kinase SubstrateIBA 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	GTP-Binding Proteins (G-Protein)IBA 01/2019
1	SirtuinsIBA 01/2018
1	adenylate cyclase 3IBA 01/2018
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2018
1	Dopa DecarboxylaseIBA 01/2018
1	ElementsIBA 01/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2018
1	Cholinergic ReceptorsIBA 01/2018
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 01/2018
1	Chloride Channels (Chloride Channel)IBA 01/2018
1	Caveolin 1IBA 01/2018
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2017
1	neurabinIBA 01/2017
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2017
1	TenascinIBA 01/2016
1	Glycoproteins (Glycoprotein)IBA 01/2016
1	Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA 01/2015
1	MicroRNAs (MicroRNA)IBA 01/2015
1	AntioxidantsIBA 07/2014
1	Small Nuclear Ribonucleoproteins (snRNP)IBA 04/2014
1	Protein AggregatesIBA 10/2013
1	Testosterone (Sustanon)FDA Link 02/2013
1	Histamine Antagonists (Antihistamines)IBA 01/2012
1	latrepirdine (dimebon)IBA 01/2012
1	EpitopesIBA 11/2011
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 11/2011

Therapy/Procedure

7	Therapeutics 01/2021 - 02/2002
4	Lasers (Laser) 10/2022 - 03/2010